Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
WEDNESDAY, Oct. 30, 2024 -- The World Health Organization reports that tuberculosis (TB) cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths, meaning it is once again the leading cause of death from infectious disease after COVID-19 displaced it briefly during the pandemic.
"The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it, and treat it," WHO Director-General Tedros Adhanom Ghebreyesus, M.D., said in an agency news release. "WHO urges all countries to make good on the concrete commitments they have made to expand the use of those tools, and to end TB."
Some countries are hit harder by the disease than others: It continues to mostly affect people in Southeast Asia, Africa and the Western Pacific. India, Indonesia, China, the Philippines, and Pakistan account for more than half of the world's cases, the WHO noted.
According to the report, 55 percent of people who developed TB were men, while 33 percent were women and 12 percent were children and young adolescents. Many of the new TB cases were driven by five major risk factors: undernutrition, HIV infection, alcohol use disorders, smoking (especially among men), and diabetes.
Tackling these issues, along with other social determinants such as poverty, requires a coordinated approach, the WHO added.
"We are confronted with a multitude of formidable challenges: funding shortfalls and catastrophic financial burden on those affected, climate change, conflict, migration and displacement, pandemics, and drug-resistant tuberculosis, a significant driver of antimicrobial resistance," Tereza Kasaeva, M.D., director of the WHO Global Tuberculosis Programme, said in the agency news release. "It is imperative that we unite across all sectors and stakeholders, to confront these pressing issues and ramp up our efforts."
Global Tuberculosis Report 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-31 12:00
Read more
- Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
- Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma
- First Patients Dosed in Phase 1a/b Clinical Trial of RGT-61159, an Oral Small Molecule Targeting MYB, in Adenoid Cystic Carcinoma and Colorectal Cancer
- Brain Zap Treatment Could Get Arms, Hands Moving After Head Injury
- Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
- Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions